Publication
HMRC publishes new lifetime allowance guidance newsletter
United Kingdom | Publication | January 2024
As we have previously reported, the Budget on March 15, 2023, announced the abolition of the lifetime allowance from the start of the 2024 to 2025 tax year.
On December 20, 2023, HMRC published a newsletter dedicated to the progress of the abolition of the LTA, which confirms:
- HMRC has received input from its technical consultation on the draft Finance Bill 2024. The legislation confirms a member's pension commencement lump sum will be free from income tax up to the permitted maximum. The newsletter also confirms the introduction and operation of the new pension commencement excess lump sum (PCELS). A lump sum that exceeds the permitted maximum and does not qualify as a PCELS will be an unauthorised payment
- Payment of a trivial commutation lump sums, winding up lump sums and small lump sums will not reduce a member's available lump sum allowance, or lump sum and death benefit allowance. The newsletter also includes an example of the valuation of pension rights for calculating the commutation limit.
- The interim process for personal representatives to report to HMRC when they identify a chargeable amount after payment of a defined benefits lump sum death benefit or uncrystallised funds lump sum death benefit will be retained and expanded from 2024/25. The process will be updated from April 6, 2025, including new guidance and a dedicated form to complete
Recent publications
Publication
The GCR Guide to Life Sciences – Product denigration
Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .